vs

Side-by-side financial comparison of Fulgent Genetics, Inc. (FLGT) and Star Equity Holdings, Inc. (STRR). Click either name above to swap in a different company.

Fulgent Genetics, Inc. is the larger business by last-quarter revenue ($71.1M vs $56.8M, roughly 1.3× Star Equity Holdings, Inc.). On growth, Star Equity Holdings, Inc. posted the faster year-over-year revenue change (69.0% vs -3.2%). Over the past eight quarters, Star Equity Holdings, Inc.'s revenue compounded faster (29.5% CAGR vs 0.1%).

Fulgent Genetics, Inc. is a molecular diagnostics technology firm that develops and offers genetic testing services including carrier screening, oncology testing, infectious disease detection, and hereditary condition analysis, serving clinical providers, pharma firms, research institutions and public health groups primarily in North America.

Artists Equity is an American production company founded by actors and filmmakers Ben Affleck and Matt Damon in November 2022.

FLGT vs STRR — Head-to-Head

Bigger by revenue
FLGT
FLGT
1.3× larger
FLGT
$71.1M
$56.8M
STRR
Growing faster (revenue YoY)
STRR
STRR
+72.2% gap
STRR
69.0%
-3.2%
FLGT
Faster 2-yr revenue CAGR
STRR
STRR
Annualised
STRR
29.5%
0.1%
FLGT

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
FLGT
FLGT
STRR
STRR
Revenue
$71.1M
$56.8M
Net Profit
$-1.7M
Gross Margin
30.2%
Operating Margin
21.1%
-0.2%
Net Margin
-3.0%
Revenue YoY
-3.2%
69.0%
Net Profit YoY
-192.1%
EPS (diluted)
$0.04
$-0.49

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
FLGT
FLGT
STRR
STRR
Q1 26
$71.1M
Q4 25
$83.3M
$56.8M
Q3 25
$84.1M
$48.0M
Q2 25
$81.8M
$35.5M
Q1 25
$73.5M
$31.9M
Q4 24
$76.2M
$33.6M
Q3 24
$71.7M
$36.9M
Q2 24
$71.0M
$35.7M
Net Profit
FLGT
FLGT
STRR
STRR
Q1 26
Q4 25
$-23.4M
$-1.7M
Q3 25
$-6.6M
$-1.8M
Q2 25
$-19.0M
$-688.0K
Q1 25
$-11.5M
$-1.8M
Q4 24
$-5.9M
$-585.0K
Q3 24
$-14.6M
$-846.0K
Q2 24
$-8.7M
$-441.0K
Gross Margin
FLGT
FLGT
STRR
STRR
Q1 26
30.2%
Q4 25
39.1%
Q3 25
42.2%
43.0%
Q2 25
42.1%
Q1 25
38.6%
Q4 24
41.8%
Q3 24
37.3%
50.5%
Q2 24
37.3%
Operating Margin
FLGT
FLGT
STRR
STRR
Q1 26
21.1%
Q4 25
-43.5%
-0.2%
Q3 25
-18.3%
-3.4%
Q2 25
-24.1%
-0.6%
Q1 25
-26.9%
-5.4%
Q4 24
-21.2%
-0.4%
Q3 24
-23.8%
-1.2%
Q2 24
-26.6%
-0.5%
Net Margin
FLGT
FLGT
STRR
STRR
Q1 26
Q4 25
-28.1%
-3.0%
Q3 25
-7.9%
-3.7%
Q2 25
-23.2%
-1.9%
Q1 25
-15.7%
-5.5%
Q4 24
-7.7%
-1.7%
Q3 24
-20.4%
-2.3%
Q2 24
-12.3%
-1.2%
EPS (diluted)
FLGT
FLGT
STRR
STRR
Q1 26
$0.04
Q4 25
$-0.49
Q3 25
$-0.54
Q2 25
$-0.23
Q1 25
$-0.59
Q4 24
$-0.21
Q3 24
$-0.28
Q2 24
$-0.15

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
FLGT
FLGT
STRR
STRR
Cash + ST InvestmentsLiquidity on hand
$23.4M
$10.3M
Total DebtLower is stronger
Stockholders' EquityBook value
$65.7M
Total Assets
$1.2B
$113.2M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
FLGT
FLGT
STRR
STRR
Q1 26
$23.4M
Q4 25
$50.2M
$10.3M
Q3 25
$117.6M
$15.4M
Q2 25
$87.9M
$16.8M
Q1 25
$67.3M
$16.6M
Q4 24
$55.1M
$17.0M
Q3 24
$58.0M
$15.8M
Q2 24
$65.1M
$14.7M
Total Debt
FLGT
FLGT
STRR
STRR
Q1 26
Q4 25
Q3 25
$6.5M
Q2 25
Q1 25
Q4 24
$0
Q3 24
Q2 24
Stockholders' Equity
FLGT
FLGT
STRR
STRR
Q1 26
Q4 25
$1.1B
$65.7M
Q3 25
$1.1B
$67.8M
Q2 25
$1.1B
$40.1M
Q1 25
$1.1B
$39.5M
Q4 24
$1.1B
$40.4M
Q3 24
$1.1B
$42.9M
Q2 24
$1.1B
$42.6M
Total Assets
FLGT
FLGT
STRR
STRR
Q1 26
$1.2B
Q4 25
$1.2B
$113.2M
Q3 25
$1.2B
$117.1M
Q2 25
$1.2B
$55.6M
Q1 25
$1.2B
$53.2M
Q4 24
$1.2B
$52.6M
Q3 24
$1.2B
$52.6M
Q2 24
$1.2B
$52.6M
Debt / Equity
FLGT
FLGT
STRR
STRR
Q1 26
Q4 25
Q3 25
0.10×
Q2 25
Q1 25
Q4 24
0.00×
Q3 24
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
FLGT
FLGT
STRR
STRR
Operating Cash FlowLast quarter
$-7.3M
Free Cash FlowOCF − Capex
$-9.0M
FCF MarginFCF / Revenue
-15.8%
Capex IntensityCapex / Revenue
3.0%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-13.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
FLGT
FLGT
STRR
STRR
Q1 26
Q4 25
$-78.1M
$-7.3M
Q3 25
$11.1M
$-2.7M
Q2 25
$-30.2M
$139.0K
Q1 25
$-4.4M
$-802.0K
Q4 24
$25.0M
$-2.8M
Q3 24
$-15.5M
$1.3M
Q2 24
$4.3M
$-4.3M
Free Cash Flow
FLGT
FLGT
STRR
STRR
Q1 26
Q4 25
$-83.1M
$-9.0M
Q3 25
$5.1M
$-3.4M
Q2 25
$-37.0M
$102.0K
Q1 25
$-9.1M
$-808.0K
Q4 24
$21.2M
$-2.8M
Q3 24
$-35.0M
$1.3M
Q2 24
$-8.7M
$-4.3M
FCF Margin
FLGT
FLGT
STRR
STRR
Q1 26
Q4 25
-99.7%
-15.8%
Q3 25
6.0%
-7.0%
Q2 25
-45.2%
0.3%
Q1 25
-12.5%
-2.5%
Q4 24
27.9%
-8.3%
Q3 24
-48.8%
3.4%
Q2 24
-12.2%
-12.0%
Capex Intensity
FLGT
FLGT
STRR
STRR
Q1 26
Q4 25
6.0%
3.0%
Q3 25
7.2%
1.3%
Q2 25
8.3%
0.1%
Q1 25
6.4%
0.0%
Q4 24
5.0%
0.1%
Q3 24
27.2%
0.0%
Q2 24
18.2%
0.0%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

FLGT
FLGT

Segment breakdown not available.

STRR
STRR

Revenue From Other Contracts With Customers$27.6M49%
Other$24.3M43%
Energy Services Segment$4.9M9%

Related Comparisons